The healthcare revenue cycle management (RCM) technology company Janus receives strategic investment
With Janus' technology, companies can generate as high as a 2% increased net revenue and reduction of costs of collection by as much as 35%.
top of page
Upload a PDF
Max File Size 15MB
Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
-
MedNews on financings, strategic relationships, products, services and technology, including launches
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
.jpg)
Financing and Investment
- 6 days ago
- 3 min
FIRE1 raises $25 Million for the development of its remote monitoring for heart failure patients
Hemodynamic monitoring in heart failure has tremendous potential to improve care for patients and reduce the need for hospitalizations.
- Mar 15
- 2 min
Advanced Medical Device Technologies to commercialize its warming device for infused fluids
We’re now able to complete the FDA Premarket Notification, also known as 510(k), for what we believe will be a significant advancement.
- Mar 13
- 3 min
Streamline Healthcare Solutions receives strategic investment from Gauge Capital
The Company serves a broad range of behavioral health end-markets including mental health, substance abuse, and developmental disability.
- Mar 7
- 2 min
AI prevention-centric healthcare and wellness VivaWell Raises $1.6 Million to expand in Mexico
VivaWell is an aggregator of healthcare and wellness services and utilizes artificial intelligence and machine learning to create solutions
- Mar 4
- 3 min
Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer
Prana Thoracic is developing the first minimally invasive, lung-sparing device for early intervention of suspicious pulmonary nodules.
- Feb 22
- 3 min
Rare and orphan disease focused Quoin Pharmaceuticals (Nasdaq: QNRX) prices $7 million placement
Quoin Pharmaceuticals Ltd. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products
- Feb 17
- 3 min
LifeArc Ventures participates in a $16 million financing for Maxion Therapeutics for antibody drugs
The funds will be used for the development of novel biologics targeting ion channels and G-procoupled receptors
- Feb 15
- 3 min
Great Product Ventures initiates strategic relationship with life sciences regulatory services firm
Great Product Ventures is a venture development firm whose mission is to identify the top European Companies to commercialize and fund...
- Feb 14
- 2 min
Nasdaq-listed SeqLL prices $1.8 million offering
The gross proceeds to the Company from the Offering are estimated to be approximately $1.8 million.
- Feb 11
- 3 min
Nasdaq-listed ReShape Lifesciences announces $10.2 million public offering
ReShape Lifesciences is America's premier weight-loss and metabolic health-solutions company.
- Feb 1
- 4 min
Panbela prices $15 million public offering
CPP-1X (eflornithine) is being developed as a single agent tablet or high dose power sachet for several indications including prevention...
- Jan 10
- 3 min
Trinity Biotech partners with imaware to deliver diagnostic testing solutions for digital health
imaware’s mission is to empower the health of humanity by providing testing and technology solutions for healing at scale.
- Jan 8
- 3 min
Global tele-dermatology company MedX Health closes $1.5 million convertible debenture
MedX, y.headquartered in Ontario, Canada, is a leading medical device and software company
- Jan 7
- 3 min
Retinal Degeneration Fund participates in a $78 million funding round for Perceive Biotherapeutics
AMD is the leading cause of blindness in people 55 and older, affecting more than 150 million people worldwide and 10 million people in US
- Jan 4
- 3 min
Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea
Enrollment for the clinical trials is expected to begin in the second quarter of 2023
- Dec 17, 2022
- 2 min
PaxeraHealth closes on financing to accelerate its medical imaging and AI authoring platform
PaxeraHealth Corp. is a world-leading, innovative medical imaging platform developer based in Boston,
- Dec 11, 2022
- 1 min
iBio, an AI-driven innovator of precision antibody immunotherapies, closes $3.5 million financing
iBio’s mission is to decrease drug failures, shorten drug development timelines, and open up new frontiers against the most promising...
- Nov 24, 2022
- 4 min
Nyra Medical closes on $20 Million to advance its transcatheter heart valve repair technology
Nyra Medical is a medical device company with the motto "simplifying transcatheter repair of heart valves…one valve at a time"
- Nov 23, 2022
- 3 min
scPharmaceuticals Announces Pricing of $50 Million Public Offering
scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential...
- Nov 18, 2022
- 3 min
Fathom, the leader in medical coding automation, closes $46 million financing
Widespread autonomous medical coding is one of the first steps to rebuilding America’s healthcare payments system...
- Nov 11, 2022
- 3 min
White Oak Healthcare provides financing for United Dental's acquisitions in four states
UDC’s first wave of practices features a mix of specialty and general practice dentists located in key markets in four states.
- Nov 9, 2022
- 7 min
Led by Medtronic, Cloud DX Announces Consortium to Advance Affordable Hospital-Level Care at Home
The remote patient monitoring system project will be led by Medtronic and include expertise and technology from a consortium of partners.
- Oct 28, 2022
- 2 min
Biotech Fund launched with $100 Million of Assets to Focus on Better Drugs, Devices and Diagnostics
Its initial investments include Neuralink, Elon Musk’s brain-computer interface start-up, and Kling Biotherapeutics.
- Oct 25, 2022
- 3 min
Shadowbox, a healthcare automation solutions innovator, closes “up to” $6 million financing
By powering a browser with security, AI, and user-driven cross-application connections. Shadowbox offers instant integration and automation.
- Oct 15, 2022
- 4 min
Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development
The company is focused on innovative targeted radiopharmaceuticals for the diagnosis, monitoring, and therapy of cancer.
- Oct 8, 2022
- 4 min
RadioMedix raises $40 million to advance its alpha therapy platform for oncology
Targeted alpha therapies are currently considered one of the most advanced technologies available to treat patients with incurable cancers.
- Oct 2, 2022
- 4 min
CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus
“EpiSmart has the potential to be a game-changer for the treatment for keratoconus.
- Sep 3, 2022
- 5 min
Early-stage novel cell therapy company Neukio Biotherapeutics closes a $50 million financing
The transition from traditional small molecules and antibodies to the era of cell therapy is a great leap in drug design and manufacturing
- Aug 16, 2022
- 2 min
CareHarmony raises $15 million to fuel the development of its proprietary CareBlocks technology
This capital will help us deliver on our commitment to bring efficient, impactful, and measurable virtual care to every patient.
- Aug 13, 2022
- 2 min
Clario invests in new technology to reduce translation times for clinical trials
For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.
- Aug 8, 2022
- 2 min
Helius Medical Technologies Prices $18 Million Public Offering
The Company’s commercial product is the Portable Neuromodulation Stimulator (PoNS™).
- Aug 5, 2022
- 2 min
Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy
Immunis’ FDA Phase 1/2a clinical trial is a study to assess IMM01-STEM in elderly participants with muscle atrophy.
- Aug 3, 2022
- 3 min
IDRx raises $122 million to transform cancer treatment with precision combination therapies
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies.
- Jul 28, 2022
- 2 min
PreciPoint raises €10 million to advance the digitization of intraoperable cancer surgery
PreciPoint is an ISO 13485 certified medical device company and one of the top startups in Germany.
- Jul 26, 2022
- 2 min
causaLens partners with the Mayo Clinic to further develop non-invasive methods for cancer screening
There is an urgent clinical need for techniques that can reliably detect early-stage colorectal cancers via non-invasive methods.
- Jul 23, 2022
- 3 min
Theator raises an additional $24 million for its Surgical Intelligence Platform for operating rooms
Theator is pioneering the Surgical Intelligence revolution, harnessing advanced AI and computer vision technology
- Jul 16, 2022
- 3 min
SIFT HEALTHCARE raises $9 million for its AI-based Payments Intelligence Platform for reimbursement
This financing supports the company’s accelerating sales of its denials management and patient payment solutions
- Jul 15, 2022
- 3 min
Manifold Bio Raises $40 Million for its next-generation protein engineering platform
Manifold Bio is a fully-integrated biotechnology company pursuing a pipeline of targeting-enhanced protein therapeutics.
- Jul 9, 2022
- 4 min
Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology
There’s a major unmet need to improve outcomes for cancer patients and Kernal Bio has built a strong rational for the use of its novel mRNA
- Jun 29, 2022
- 2 min
Deep Blue Medical Advances closes financing to scale up its T-Line Hernia Mesh to meet demand
Deep Blue Medical Advances is developing novel hernia surgery products to address hernia occurrence and recurrence
- Jun 25, 2022
- 4 min
Health Tech Start-up Spry Raises Funds to Advance Practice Management for Physical Rehabilitation
Spry is a purpose built platform for the physical rehabilitation industry.
- Jun 22, 2022
- 2 min
Medical device company Artio Medical raises an additional $28 million for vascular and cardiology
Artio Medical is a medical device company committed to developing innovative products for peripheral vascular and cardiovascular diseases.
- Jun 17, 2022
- 3 min
NOWATCH raises $8.7 million to advance its wearable device to predict stress through cortisol levels
In partnering with Philips, NOWATCH’s unique ability to help users understand and navigate their cortisol levels is set...
- Jun 12, 2022
- 2 min
Degron Therapeutics Raises $22 Million for its Molecular-Glue-Based Targeted Protein Degradation
The company’s pipeline includes a growing number of preclinical compounds for oncology, inflammation, metabolic disease, and rare diseases.
- Jun 8, 2022
- 3 min
L7 Informatics Raises $38 Million to Accelerate Innovation in Precision Healthcare
Over the last decade, personalized healthcare has spread beyond oncology and now comprises almost half of all new drugs in development.
- Jun 7, 2022
- 2 min
OriCiro Closes on Financing to Advance Cell-Free Cloning technology for Large Circular DNA
OriCiro Genomics’ unique cell-free DNA technology has a tremendous potential for business applications, particularly for healthcare.
- May 27, 2022
- 4 min
Parallel Learning closes on $20 million to test, diagnose and empower special needs students
Our mission is to work hand-in-hand with school districts and families to deliver the highest quality developmental services.
- May 23, 2022
- 1 min
Today’s climate for cross-border transactions and venture capital financing for medical devices
A MedTalks commentary by Jeffrey Friedland
- May 20, 2022
- 4 min
ApiJect raises $111 million to transform the fill, finish and delivery of injectable vaccines
ApiJect is developing a truly innovative technology, that could transform the manufacturing and delivery of life-saving injectable drugs.
bottom of page